{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:23:29Z","timestamp":1740176609170,"version":"3.37.3"},"reference-count":35,"publisher":"Federacion Colombiana de Obstetricia y Ginecologia","issue":"4","license":[{"start":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T00:00:00Z","timestamp":1609286400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002945","name":"Direcci\u00f3n de Investigaci\u00f3n, Universidad Nacional de Colombia","doi-asserted-by":"publisher","award":["DIB: 35975"],"award-info":[{"award-number":["DIB: 35975"]}],"id":[{"id":"10.13039\/501100002945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Colomb. Obstet. Ginecol."],"abstract":"<jats:p>Objetivo: establecer la prevalencia de infecci\u00f3n anal por virus de papiloma humano de alto riesgo (VPH- AR) y citolog\u00eda anal anormal en mujeres con displasia cervical confirmada. Materiales y m\u00e9todos: estudio de corte transversal que incluy\u00f3 pacientes entre 30 y 65 a\u00f1os con diagn\u00f3stico nuevo de displasia cervical por histopatolog\u00eda, en dos unidades de colposcopia y patolog\u00eda del tracto genital inferior (una de car\u00e1cter p\u00fablico y otra privada) entre diciembre de 2017 y abril de 2019. Se excluyeron mujeres con infecci\u00f3n por virus de inmunodeficiencia humana (VIH), inmuno-compromiso (uso de esteroides, trasplante, quimioterapia), en embarazo o con malformaciones anorrectales. Muestreo consecutivo. Se evaluaron variables sociodemogr\u00e1ficas, tipo de relaciones sexuales, el grado de displasia cervical, resultado positivo de prueba de reacci\u00f3n en cadena de la polimerasa para VPH de alto riesgo en canal anal y tipo de VPH-AR identificado (16-18 u otro). Se utiliz\u00f3 estad\u00edstica descriptiva. Resultados: de 188 candidatas a ingresar se incluyeron 100 pacientes en el an\u00e1lisis, se encontr\u00f3 una prevalencia de 32 % de infecci\u00f3n por VPH de alto riesgo y de 2,8% de citolog\u00eda anal anormal (ASCUS) en el canal anal. El 68,8% de las infecciones por VPH-AR en el canal anal correspondi\u00f3 a genotipos de VPH-AR diferentes a 16 o 18. Conclusiones: la prevalencia de infecci\u00f3n anal por VPH-AR en mujeres con displasia cervical fue del 32%. Es importante determinar la utilidad del tamizaje del compromiso de la mucosa anal por virus VPH de alto riesgo de c\u00e1ncer en mujeres con displasia cervical. Se requieren estudios sobre el pron\u00f3stico de la infecci\u00f3n anal por VPH-AR en las mujeres con displasia cervical.<\/jats:p>","DOI":"10.18597\/rcog.3558","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T20:28:29Z","timestamp":1609273709000},"page":"345-355","source":"Crossref","is-referenced-by-count":3,"title":["Prevalencia de infecci\u00f3n por virus del papiloma humano de alto riesgo y citolog\u00eda anormal en la zona de transformaci\u00f3n anal en mujeres con displasia cervical. Bogot\u00e1, Colombia, 2017-2019"],"prefix":"10.18597","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7531-9230","authenticated-orcid":false,"given":"Cristhiam David","family":"S\u00e1nchez-Corredor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2213-147X","authenticated-orcid":false,"given":"M\u00f3nica","family":"Guerrero-Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1004-6331","authenticated-orcid":false,"given":"Jorge Andr\u00e9s","family":"Rubio-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8302-5841","authenticated-orcid":false,"given":"Edith","family":"A\u0301ngel-Mu\u0308ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9693-3125","authenticated-orcid":false,"given":"Gustavo","family":"Rey-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7388-0385","authenticated-orcid":false,"given":"Luz Amparo","family":"Di\u0301az-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7913","published-online":{"date-parts":[[2020,12,30]]},"reference":[{"key":"86469","doi-asserted-by":"crossref","unstructured":"Roberts JR, Siekas LL, Kaz AM. Anal intraepithelial neoplasia: A review of diagnosis and management. World J Gastrointest Oncol. 2017;9(2):50-61. https:\/\/doi.org\/10.4251\/wjgo.v9.i2.50","DOI":"10.4251\/wjgo.v9.i2.50"},{"key":"86470","doi-asserted-by":"crossref","unstructured":"Messick CA, Rodriguez-Bigas MA. Anal Dysplasia. Surg Oncol Clin N Am. 2017;26(1):33-43. https:\/\/doi.org\/10.1016\/j.soc.2016.07.005","DOI":"10.1016\/j.soc.2016.07.005"},{"key":"86471","doi-asserted-by":"crossref","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer Statistics. CA Cancer J Clin. 2012;62(1):10-29. https:\/\/doi.org\/10.3322\/caac.20138","DOI":"10.3322\/caac.20138"},{"key":"86472","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. Cancer Stat Facts: Anal Cancer. 2018. Disponible en: https:\/\/seer.cancer.gov\/statfacts\/html\/anus.html"},{"key":"86473","unstructured":"Bruni L, Albero G, Serrano B, Mena M, G\u00f3mez D, Mu\u00f1oz J, et al. Human papillomavirus and related diseases in the world - Summary report. ICO\/IARC Inf Cent HPV Cancer (HPV Inf Centre). 2019;307. Disponible en: https:\/\/hpvcentre.net\/statistics\/reports\/XWX.pdf"},{"key":"86474","doi-asserted-by":"crossref","unstructured":"Saleem AM, Paulus JK, Shapter AP, Baxter NN, Roberts PL, Ricciardi R. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm. Obstet Gynecol. 2011;117(3):643-9. https:\/\/doi.org\/10.1097\/AOG.0b013e31820bfb16","DOI":"10.1097\/AOG.0b013e31820bfb16"},{"key":"86475","doi-asserted-by":"crossref","unstructured":"Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, et al. Cervical determinants of anal HPV infection and high-grade anal lesions in women: A collaborative pooled analysis. Lancet Infect Dis. 2019;19(8):880-91. https:\/\/doi.org\/10.1016\/S1473-3099(19)30164-1","DOI":"10.1016\/S1473-3099(19)30164-1"},{"key":"86476","doi-asserted-by":"crossref","unstructured":"Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, et al. Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: The Hawaii HPV cohort study. J Infect Dis. 2010;201(9):1331-9. https:\/\/doi.org\/10.1086\/651620","DOI":"10.1086\/651620"},{"key":"86477","doi-asserted-by":"crossref","unstructured":"Slama J, Sehnal B, Dusek L, Zima T, Cibula D. Impact of risk factors on prevalence of anal HPV infection in women with simultaneous cervical lesion. Neoplasma. 2015;62(2):308-14. https:\/\/doi.org\/10.4149\/neo_2015_037","DOI":"10.4149\/neo_2015_037"},{"key":"86478","doi-asserted-by":"crossref","unstructured":"Sand FL, Munk C, Jensen SM, Svahn MF, Frederiksen K, Kj\u00e6r SK. Long-term risk for noncervical anogenital cancer in women with previously diagnosed high-grade cervical intraepithelial neoplasia: A Danish nationwide cohort study. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1090-7. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-1291","DOI":"10.1158\/1055-9965.EPI-15-1291"},{"key":"86479","doi-asserted-by":"crossref","unstructured":"Stier EA, Sebring MC, Mendez AE, Ba FS, Trimble DD, Chiao EY. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: A systematic review. Am J Obstet Gynecol. 2015;213(3):278-309. https:\/\/doi.org\/10.1016\/j.ajog.2015.03.034","DOI":"10.1016\/j.ajog.2015.03.034"},{"key":"86480","doi-asserted-by":"crossref","unstructured":"Alemany L, Saunier M, Alvarado-Cabrero I, Quir\u00f5s B, Salmeron J, Shin HR, et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer. 2015;136(1):98-107. https:\/\/doi.org\/10.1002\/ijc.28963","DOI":"10.1002\/ijc.28963"},{"key":"86481","doi-asserted-by":"crossref","unstructured":"Bregar AJ, Cronin B, Luis C, Disilvestro P, Schechter S, Pisharodi L, et al. Anal and cervical high-risk human papillomavirus genotyping in women with and without genital neoplasia. 2018;22(2):115-9. https:\/\/doi.org\/10.1097\/LGT.0000000000000368","DOI":"10.1097\/LGT.0000000000000368"},{"key":"86482","doi-asserted-by":"crossref","unstructured":"Daling JR, Sherman KJ, Hislop TG, Maden C, Mandelson MT, Beckmann AM, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol. 1992;135(2):180-9. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116270","DOI":"10.1093\/oxfordjournals.aje.a116270"},{"key":"86483","doi-asserted-by":"crossref","unstructured":"Benevolo M, Don\u00e0 MG, Ravenda PS, Chiocca S. Anal human papillomavirus infection: Prevalence, diagnosis and treatment of related lesions. Expert Rev Anti Infect Ther. 2016;14(5):465-77. https:\/\/doi.org\/10.1586\/14787210.2016.1174065","DOI":"10.1586\/14787210.2016.1174065"},{"key":"86484","doi-asserted-by":"crossref","unstructured":"Scholefield JH, Castle MT, Watson NFS. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg. 2005;92(9):1133-6. https:\/\/doi.org\/10.1002\/bjs.4994","DOI":"10.1002\/bjs.4994"},{"key":"86485","doi-asserted-by":"crossref","unstructured":"de Carvalho NS, Ferreira AM, Tremel Bueno CC. HPV infection and intraepithelial lesions from the anal region: How to diagnose? Brazilian J Infect Dis. 2011;15(5):473-7. https:\/\/doi.org\/10.1016\/s1413-8670(11)70230-6","DOI":"10.1016\/S1413-8670(11)70230-6"},{"key":"86486","doi-asserted-by":"crossref","unstructured":"Pineda CE, Berry JM, Jay N, Palefsky JM, Welton ML. High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: A ten-year experience. Dis Colon Rectum. 2008;51(6):829-37. https:\/\/doi.org\/10.1007\/s10350-008-9233-4","DOI":"10.1007\/s10350-008-9233-4"},{"key":"86487","doi-asserted-by":"crossref","unstructured":"Scholefield JH, Harris D, Radcliffe A. Guidelines for management of anal intraepithelial neoplasia. Color Dis. 2011;13(Suppl 1):3-10. https:\/\/doi.org\/10.1111\/j.1463-1318.2010.02494.x","DOI":"10.1111\/j.1463-1318.2010.02494.x"},{"key":"86488","doi-asserted-by":"crossref","unstructured":"Clarke MA, Wentzensen N. Strategies for screening and early detection of anal cancers: A Narrative and Systematic Review and Meta-Analysis of Cytology, HPV Testing, and Other Biomarkers. Cancer Cytopathol. 2018;126(7):447-60. https:\/\/doi.org\/10.1002\/cncy.22018","DOI":"10.1002\/cncy.22018"},{"key":"86489","doi-asserted-by":"crossref","unstructured":"Palefsky JM, Rubin M. The epidemiology of anal human papillomavirus and related neoplasia. Obstet Gynecol Clin North Am. 2009;36(1):187-200. https:\/\/doi.org\/10.1016\/j.ogc.2009.02.003","DOI":"10.1016\/j.ogc.2009.02.003"},{"key":"86490","doi-asserted-by":"crossref","unstructured":"Salit IE, Lytwyn A, Raboud J, Sano M, Chong S, Diong C, et al. The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening. AIDS. 2010;24(9):1307-13. https:\/\/doi.org\/10.1097\/QAD.0b013e328339e592","DOI":"10.1097\/QAD.0b013e328339e592"},{"key":"86491","doi-asserted-by":"crossref","unstructured":"Padilla-Espa\u00f1a L, Repiso-Jim\u00e9nez B, Fernando F-S, Frieyro-Elicegui M, Fern\u00e1ndez-Moranoa T, Peredac T, et al. Utilidad de la detecci\u00f3n del virus del papiloma humano en el cribado de neoplasia intraepitelial anal en pacientes con conductas de riesgo. Enferm Infecc Microbiol Clin. 2014;32(9):560-4. https:\/\/doi.org\/10.1016\/j.eimc.2014.03.008","DOI":"10.1016\/j.eimc.2014.03.008"},{"key":"86492","doi-asserted-by":"crossref","unstructured":"do Socorro Nobre M, Jacyntho CM, Eleut\u00e9rio J, Giraldo PC, Gon\u00e7alves AK. Abnormal anal cytology risk in women with known genital squamous intraepithelial lesion. Brazilian J Infect Dis. 2016;20(3):294-7. https:\/\/doi.org\/10.1016\/j.bjid.2016.01.008","DOI":"10.1016\/j.bjid.2016.01.008"},{"key":"86493","doi-asserted-by":"crossref","unstructured":"Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Schwartz L, Lorey TS, et al. Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16\/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. AIDS. 2012;26(17):2185-92. https:\/\/doi.org\/10.1097\/QAD.0b013e328359f255","DOI":"10.1097\/QAD.0b013e328359f255"},{"key":"86494","doi-asserted-by":"crossref","unstructured":"Burgos J, Hern\u00e1ndez-Losa J, Landolfi S, Guelar A, Dinares MA, Villar J, et al. The role of oncogenic human papillomavirus determination for diagnosis of high-grade anal intraepithelial neoplasia in HIVinfected MSM. AIDS. 2017;31(16):2227-33. https:\/\/doi.org\/10.1097\/QAD.0000000000001605","DOI":"10.1097\/QAD.0000000000001605"},{"key":"86495","doi-asserted-by":"crossref","unstructured":"Santoso JT, Long M, Crigger M, Wan JY, Haefner HK. Anal intraepithelial neoplasia in women with genital intraepithelial neoplasia. Obstet Gynecol. 2010;116(3):578-82. https:\/\/doi.org\/10.1097\/AOG.0b013e3181ea1834","DOI":"10.1097\/AOG.0b013e3181ea1834"},{"key":"86496","doi-asserted-by":"crossref","unstructured":"Nayar R, Wilbur DC. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. Springer International Publishing; 2015. https:\/\/doi.org\/10.1007\/978-3-319-11074-5","DOI":"10.1007\/978-3-319-11074-5"},{"key":"86497","doi-asserted-by":"crossref","unstructured":"Lefevre J, Hankins C, Pourreaux K, Voyer H, Coutl\u00e9e F. Real-time PCR assays using internal controls for quantitation of HPV-16 and beta-globin DNA in cervicovaginal lavages. J Virol Methods. 2003;114(2):135-44. https:\/\/doi.org\/10.1016\/j.jviromet.2003.09.003","DOI":"10.1016\/j.jviromet.2003.09.003"},{"key":"86498","doi-asserted-by":"crossref","unstructured":"V\u00e9o CAR, Saad SS, Nicolau SM, Melani AGF, Denadai MVA. Study on the prevalence of human papillomavirus in the anal canal of women with cervical intraepithelial neoplasia grade III. Eur J Obstet Gynecol Reprod Biol. 2008;140(1):103-7. https:\/\/doi.org\/10.1016\/j.ejogrb.2008.02.024","DOI":"10.1016\/j.ejogrb.2008.02.024"},{"key":"86499","doi-asserted-by":"crossref","unstructured":"Nasioutziki M, Chatzistamatiou K, Loufopoulos PD, Vavoulidis E, Tsampazis N, Pratilas GC, et al. Cervical, anal and oral HPV detection and HPV type concordance among women referred for colposcopy. Infect Agent Cancer. 2020;15(1):22. https:\/\/doi.org\/10.1186\/s13027-020-00287-7","DOI":"10.1186\/s13027-020-00287-7"},{"key":"86500","doi-asserted-by":"crossref","unstructured":"Sehnal B, Dusek L, Cibula D, Zima T, Halaska M, Driak D, et al. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia. J Clin Virol Publ Pan Am Soc Clin Virol. 2014;59(1):18-23. https:\/\/doi.org\/10.1016\/j.jcv.2013.11.004","DOI":"10.1016\/j.jcv.2013.11.004"},{"key":"86501","doi-asserted-by":"crossref","unstructured":"Donaire C, Reillo M, Mart\u00ednez-Escoriza JC, L\u00f3pez-Fern\u00e1ndez JA. Anal study in immunocompetent women with human papillomavirus related lower genital tract pathology. Eur J Obstet Gynecol Reprod Biol. 2017;211:15-20. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.01.023","DOI":"10.1016\/j.ejogrb.2017.01.023"},{"key":"86502","doi-asserted-by":"crossref","unstructured":"Hosseini MS, Khosravi D, Farzaneh F, Ebrahimi A, Arab M, Ashraf Ganjoie T, et al. Evaluation of anal cytology in women with history of abnormal pap smear, cervical intraepithelial neoplasia, cervical cancer and high risk HPV for anogenital dysplasia. Asian Pac J Cancer Prev. 2018;19(11):3071-5. https:\/\/doi.org\/10.31557\/APJCP.2018.19.11.3071","DOI":"10.31557\/APJCP.2018.19.11.3071"},{"key":"86503","doi-asserted-by":"crossref","unstructured":"Kaufman E, Castro C, Williamson T, Lessard B, Munoz M. Acceptability of anal cancer screening tests for women living with HIV in the EVVA study. 2020; 7(1):19-26. https:\/\/doi.org\/10.3747\/co.27.5401","DOI":"10.3747\/co.27.5401"}],"container-title":["Revista Colombiana de Obstetricia y Ginecolog\u00eda"],"original-title":[],"link":[{"URL":"https:\/\/revista.fecolsog.org\/index.php\/rcog\/article\/download\/3558\/3670","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revista.fecolsog.org\/index.php\/rcog\/article\/download\/3558\/3679","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revista.fecolsog.org\/index.php\/rcog\/article\/download\/3558\/3670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T14:15:13Z","timestamp":1612188913000},"score":1,"resource":{"primary":{"URL":"https:\/\/revista.fecolsog.org\/index.php\/rcog\/article\/view\/3558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,30]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12,30]]}},"URL":"https:\/\/doi.org\/10.18597\/rcog.3558","relation":{},"ISSN":["2463-0225","0034-7434"],"issn-type":[{"type":"electronic","value":"2463-0225"},{"type":"print","value":"0034-7434"}],"subject":[],"published":{"date-parts":[[2020,12,30]]}}}